Subtotal Parathyroidectomy in Renal Failure: Still Needed after All These Years View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2001-06

AUTHORS

P. Anthony Decker, Eric P. Cohen, Kara M. DoffekB.S., Blake A. Ashley, Mary E. Bienemann, Yong Ran Zhu, Mark E. Adams, Stuart D. Wilson, Michael J. Demeure

ABSTRACT

There are scant data on the frequency of parathyroidectomy (PTX) for end-stage renal disease (ESRD). Medical therapy for ESRD and secondary hyperparathyroidism has evolved to include better dialytic urea removal and the use of calcitriol. The aim of this study was to determine whether medical therapy has changed the frequency or indications for PTX in the management of renal failure. Hospital and clinic records were analyzed to gather information on all patients undergoing PTX for secondary hyperparathyroidism (2HPT) (n = 48) and tertiary hyperparathyroidism (3HPT) (n = 26) from 1986 through 1998 at our institution. Prospective computer databases were queried for information concerning both chronic dialysis and renal transplant patients at our center. The patients were divided based on date of operation before or after 1991, a divider that separated the patients into groups before or after the widespread adoption of intravenous calcitriol treatment during hemodialysis at our institution. Over the 12 year period, the proportion of our chronic dialysis patients undergoing PTX did not change significantly, ranging from 0% to 2.5% per year. Comparing all patients undergoing PTX for 2HPT during 1986-1991 versus 1992-1998, there was no significant difference in time on dialysis [7.0 +/- 4.2 (n = 11) vs. 7.5 +/- 4.6 (n = 36) years, mean +/- SD]. The later group had higher intact parathyroid hormone (iPTH) levels [765 +/- 415 (n = 6) vs. 1377 +/- 636 (n = 28) pg/ml; p = 0.03], lower serum calcium [11.2 +/- 1.0 (n = 12) vs. 9.9 +/- 1.5 (n = 34) mg/dl; p = 0.006], and higher serum phosphate [5.7 +/- 1.6 (n = 12) vs. 7.2 +/- 2.3 (n = 31) mg/dl; p = 0.042]. Among the population of patients with transplants undergoing PTX for 3HPT, the average percent per year undergoing PTX ranged from 0% to 4.2% and did not change during the study period. Comparing the 1986-1991 group to the 1992-1998 group, the time from transplantation to PTX did not change during the study period (3.3 +/- 2.3 vs. 2.9 +/- 3.0 years; p = 0.391), and there were no significant differences between preoperative calcium levels or iPTH levels. Despite advances in dialysis technique and pharmacologic therapy, there has been no change in the proportion of dialysis patients requiring PTX for 2HPT or 3HPT. There was also no change in the time on dialysis for patients with 2HPT or the time from transplant to PTX for patients with 3HPT. Analysis of preoperative biochemical markers as evidence of disease severity suggests there was no change in indications for PTX during our study. From this information we conclude that parathyroid pathophysiology is incompletely understood and medical therapy is not optimal, resulting in a continuing need for PTX in some patients. More... »

PAGES

708-712

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s00268-001-0019-2

DOI

http://dx.doi.org/10.1007/s00268-001-0019-2

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1006336571

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/11376403


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Calcitriol", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Calcium Channel Agonists", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Hyperparathyroidism, Secondary", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Kidney Failure, Chronic", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Parathyroidectomy", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Retrospective Studies", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Medical College of Wisconsin", 
          "id": "https://www.grid.ac/institutes/grid.30760.32", 
          "name": [
            "Department of Surgery, Medical College of Wisconsin, 9200 West Wisconsin Avenue, Milwaukee, Wisconsin 53226, USA, US"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Decker", 
        "givenName": "P. Anthony", 
        "id": "sg:person.01144547155.52", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01144547155.52"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Medical College of Wisconsin", 
          "id": "https://www.grid.ac/institutes/grid.30760.32", 
          "name": [
            "Department of Internal Medicine, Medical College of Wisconsin, 9200 West Wisconsin Avenue, Milwaukee, Wisconsin 53226, USA, US"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Cohen", 
        "givenName": "Eric P.", 
        "id": "sg:person.014277375462.62", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014277375462.62"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Medical College of Wisconsin", 
          "id": "https://www.grid.ac/institutes/grid.30760.32", 
          "name": [
            "Department of Surgery, Medical College of Wisconsin, 9200 West Wisconsin Avenue, Milwaukee, Wisconsin 53226, USA, US"
          ], 
          "type": "Organization"
        }, 
        "familyName": "DoffekB.S.", 
        "givenName": "Kara M.", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Medical College of Wisconsin", 
          "id": "https://www.grid.ac/institutes/grid.30760.32", 
          "name": [
            "Department of Surgery, Medical College of Wisconsin, 9200 West Wisconsin Avenue, Milwaukee, Wisconsin 53226, USA, US"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ashley", 
        "givenName": "Blake A.", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Medical College of Wisconsin", 
          "id": "https://www.grid.ac/institutes/grid.30760.32", 
          "name": [
            "Department of Surgery, Medical College of Wisconsin, 9200 West Wisconsin Avenue, Milwaukee, Wisconsin 53226, USA, US"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Bienemann", 
        "givenName": "Mary E.", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Medical College of Wisconsin", 
          "id": "https://www.grid.ac/institutes/grid.30760.32", 
          "name": [
            "Department of Surgery, Medical College of Wisconsin, 9200 West Wisconsin Avenue, Milwaukee, Wisconsin 53226, USA, US"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Zhu", 
        "givenName": "Yong Ran", 
        "id": "sg:person.0675722264.21", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0675722264.21"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Medical College of Wisconsin", 
          "id": "https://www.grid.ac/institutes/grid.30760.32", 
          "name": [
            "Department of Surgery, Medical College of Wisconsin, 9200 West Wisconsin Avenue, Milwaukee, Wisconsin 53226, USA, US"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Adams", 
        "givenName": "Mark E.", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Medical College of Wisconsin", 
          "id": "https://www.grid.ac/institutes/grid.30760.32", 
          "name": [
            "Department of Surgery, Medical College of Wisconsin, 9200 West Wisconsin Avenue, Milwaukee, Wisconsin 53226, USA, US"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Wilson", 
        "givenName": "Stuart D.", 
        "id": "sg:person.01333432724.26", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01333432724.26"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Medical College of Wisconsin", 
          "id": "https://www.grid.ac/institutes/grid.30760.32", 
          "name": [
            "Department of Surgery, Medical College of Wisconsin, 9200 West Wisconsin Avenue, Milwaukee, Wisconsin 53226, USA, US"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Demeure", 
        "givenName": "Michael J.", 
        "id": "sg:person.01121231554.53", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01121231554.53"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1002/(sici)1098-2388(199703/04)13:2<73::aid-ssu2>3.0.co;2-z", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1003039741"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1159/000188833", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1020421807"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf02385267", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1039906294", 
          "https://doi.org/10.1007/bf02385267"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf02385267", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1039906294", 
          "https://doi.org/10.1007/bf02385267"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2001-06", 
    "datePublishedReg": "2001-06-01", 
    "description": "There are scant data on the frequency of parathyroidectomy (PTX) for end-stage renal disease (ESRD). Medical therapy for ESRD and secondary hyperparathyroidism has evolved to include better dialytic urea removal and the use of calcitriol. The aim of this study was to determine whether medical therapy has changed the frequency or indications for PTX in the management of renal failure. Hospital and clinic records were analyzed to gather information on all patients undergoing PTX for secondary hyperparathyroidism (2HPT) (n = 48) and tertiary hyperparathyroidism (3HPT) (n = 26) from 1986 through 1998 at our institution. Prospective computer databases were queried for information concerning both chronic dialysis and renal transplant patients at our center. The patients were divided based on date of operation before or after 1991, a divider that separated the patients into groups before or after the widespread adoption of intravenous calcitriol treatment during hemodialysis at our institution. Over the 12 year period, the proportion of our chronic dialysis patients undergoing PTX did not change significantly, ranging from 0% to 2.5% per year. Comparing all patients undergoing PTX for 2HPT during 1986-1991 versus 1992-1998, there was no significant difference in time on dialysis [7.0 +/- 4.2 (n = 11) vs. 7.5 +/- 4.6 (n = 36) years, mean +/- SD]. The later group had higher intact parathyroid hormone (iPTH) levels [765 +/- 415 (n = 6) vs. 1377 +/- 636 (n = 28) pg/ml; p = 0.03], lower serum calcium [11.2 +/- 1.0 (n = 12) vs. 9.9 +/- 1.5 (n = 34) mg/dl; p = 0.006], and higher serum phosphate [5.7 +/- 1.6 (n = 12) vs. 7.2 +/- 2.3 (n = 31) mg/dl; p = 0.042]. Among the population of patients with transplants undergoing PTX for 3HPT, the average percent per year undergoing PTX ranged from 0% to 4.2% and did not change during the study period. Comparing the 1986-1991 group to the 1992-1998 group, the time from transplantation to PTX did not change during the study period (3.3 +/- 2.3 vs. 2.9 +/- 3.0 years; p = 0.391), and there were no significant differences between preoperative calcium levels or iPTH levels. Despite advances in dialysis technique and pharmacologic therapy, there has been no change in the proportion of dialysis patients requiring PTX for 2HPT or 3HPT. There was also no change in the time on dialysis for patients with 2HPT or the time from transplant to PTX for patients with 3HPT. Analysis of preoperative biochemical markers as evidence of disease severity suggests there was no change in indications for PTX during our study. From this information we conclude that parathyroid pathophysiology is incompletely understood and medical therapy is not optimal, resulting in a continuing need for PTX in some patients.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1007/s00268-001-0019-2", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1086446", 
        "issn": [
          "0364-2313", 
          "1432-2323"
        ], 
        "name": "World Journal of Surgery", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "6", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "25"
      }
    ], 
    "name": "Subtotal Parathyroidectomy in Renal Failure: Still Needed after All These Years", 
    "pagination": "708-712", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "1e2eb7181c8ec1614c60aa757baf9c7e89a77b2db834a9ad568835db1d03bff3"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "11376403"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "7704052"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s00268-001-0019-2"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1006336571"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s00268-001-0019-2", 
      "https://app.dimensions.ai/details/publication/pub.1006336571"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-11T00:15", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8695_00000510.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://link.springer.com/10.1007%2Fs00268-001-0019-2"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s00268-001-0019-2'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s00268-001-0019-2'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s00268-001-0019-2'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s00268-001-0019-2'


 

This table displays all metadata directly associated to this object as RDF triples.

176 TRIPLES      21 PREDICATES      43 URIs      32 LITERALS      20 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s00268-001-0019-2 schema:about N0590bd94316a4fb19b29803f39aa777c
2 N0d33bc41929240689c2adb02027b4c7e
3 N1dd5b189220c480caff8c3aefe87999a
4 N20095e9f35534bb8a8509ffa8bf2e52b
5 N40272de675b14c38ad23bc69c1c4126e
6 N4d5814d5a89647898399c4a6b7091206
7 N598ec75cd65844e9850c5f3247101dec
8 N7c326084853d4847a3252d850aca4383
9 N9de53d339f5a45e8b84ecb43b14c2267
10 Nd6b088779d924588b5d570200ba0a855
11 Ne469c9e49b2f4cec9492e3411118585d
12 anzsrc-for:11
13 anzsrc-for:1103
14 schema:author N4e6a92c9d39f4f359f3da9c82bf6cd3a
15 schema:citation sg:pub.10.1007/bf02385267
16 https://doi.org/10.1002/(sici)1098-2388(199703/04)13:2<73::aid-ssu2>3.0.co;2-z
17 https://doi.org/10.1159/000188833
18 schema:datePublished 2001-06
19 schema:datePublishedReg 2001-06-01
20 schema:description There are scant data on the frequency of parathyroidectomy (PTX) for end-stage renal disease (ESRD). Medical therapy for ESRD and secondary hyperparathyroidism has evolved to include better dialytic urea removal and the use of calcitriol. The aim of this study was to determine whether medical therapy has changed the frequency or indications for PTX in the management of renal failure. Hospital and clinic records were analyzed to gather information on all patients undergoing PTX for secondary hyperparathyroidism (2HPT) (n = 48) and tertiary hyperparathyroidism (3HPT) (n = 26) from 1986 through 1998 at our institution. Prospective computer databases were queried for information concerning both chronic dialysis and renal transplant patients at our center. The patients were divided based on date of operation before or after 1991, a divider that separated the patients into groups before or after the widespread adoption of intravenous calcitriol treatment during hemodialysis at our institution. Over the 12 year period, the proportion of our chronic dialysis patients undergoing PTX did not change significantly, ranging from 0% to 2.5% per year. Comparing all patients undergoing PTX for 2HPT during 1986-1991 versus 1992-1998, there was no significant difference in time on dialysis [7.0 +/- 4.2 (n = 11) vs. 7.5 +/- 4.6 (n = 36) years, mean +/- SD]. The later group had higher intact parathyroid hormone (iPTH) levels [765 +/- 415 (n = 6) vs. 1377 +/- 636 (n = 28) pg/ml; p = 0.03], lower serum calcium [11.2 +/- 1.0 (n = 12) vs. 9.9 +/- 1.5 (n = 34) mg/dl; p = 0.006], and higher serum phosphate [5.7 +/- 1.6 (n = 12) vs. 7.2 +/- 2.3 (n = 31) mg/dl; p = 0.042]. Among the population of patients with transplants undergoing PTX for 3HPT, the average percent per year undergoing PTX ranged from 0% to 4.2% and did not change during the study period. Comparing the 1986-1991 group to the 1992-1998 group, the time from transplantation to PTX did not change during the study period (3.3 +/- 2.3 vs. 2.9 +/- 3.0 years; p = 0.391), and there were no significant differences between preoperative calcium levels or iPTH levels. Despite advances in dialysis technique and pharmacologic therapy, there has been no change in the proportion of dialysis patients requiring PTX for 2HPT or 3HPT. There was also no change in the time on dialysis for patients with 2HPT or the time from transplant to PTX for patients with 3HPT. Analysis of preoperative biochemical markers as evidence of disease severity suggests there was no change in indications for PTX during our study. From this information we conclude that parathyroid pathophysiology is incompletely understood and medical therapy is not optimal, resulting in a continuing need for PTX in some patients.
21 schema:genre research_article
22 schema:inLanguage en
23 schema:isAccessibleForFree false
24 schema:isPartOf Na1c9fc66a6bd487b9b8fa3b4d0ccf784
25 Nc143cf8989b4426cbeb39de88ff9237e
26 sg:journal.1086446
27 schema:name Subtotal Parathyroidectomy in Renal Failure: Still Needed after All These Years
28 schema:pagination 708-712
29 schema:productId N6556a3ab92794d05963611c36c6a73d4
30 N72b3919857cb4e82b37a66b398b5a35a
31 N79e548e97ebb445aa11afad71a48f6be
32 N817d1efd97f44b86bdf5e7bfad8ed1c2
33 N9b92cfe4fd9942b3a1373828961dcdff
34 schema:sameAs https://app.dimensions.ai/details/publication/pub.1006336571
35 https://doi.org/10.1007/s00268-001-0019-2
36 schema:sdDatePublished 2019-04-11T00:15
37 schema:sdLicense https://scigraph.springernature.com/explorer/license/
38 schema:sdPublisher Ncb4f04cb01434693829216ed0711ac22
39 schema:url http://link.springer.com/10.1007%2Fs00268-001-0019-2
40 sgo:license sg:explorer/license/
41 sgo:sdDataset articles
42 rdf:type schema:ScholarlyArticle
43 N0590bd94316a4fb19b29803f39aa777c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
44 schema:name Hyperparathyroidism, Secondary
45 rdf:type schema:DefinedTerm
46 N0d33bc41929240689c2adb02027b4c7e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
47 schema:name Retrospective Studies
48 rdf:type schema:DefinedTerm
49 N1dd5b189220c480caff8c3aefe87999a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
50 schema:name Calcitriol
51 rdf:type schema:DefinedTerm
52 N20095e9f35534bb8a8509ffa8bf2e52b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
53 schema:name Kidney Failure, Chronic
54 rdf:type schema:DefinedTerm
55 N228152ef85924ba9b1876c3fc55f44c5 rdf:first N630f1364bc06428b91d01b5657f801bd
56 rdf:rest Ne64d5c54d9f145988144145292d7b74d
57 N2534e7bbe75f48c898f3d2773bd7e0f3 schema:affiliation https://www.grid.ac/institutes/grid.30760.32
58 schema:familyName Ashley
59 schema:givenName Blake A.
60 rdf:type schema:Person
61 N2a31b089d92e48daa82d28c162aa6f16 schema:affiliation https://www.grid.ac/institutes/grid.30760.32
62 schema:familyName Adams
63 schema:givenName Mark E.
64 rdf:type schema:Person
65 N40272de675b14c38ad23bc69c1c4126e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
66 schema:name Middle Aged
67 rdf:type schema:DefinedTerm
68 N4d5814d5a89647898399c4a6b7091206 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
69 schema:name Female
70 rdf:type schema:DefinedTerm
71 N4e6a92c9d39f4f359f3da9c82bf6cd3a rdf:first sg:person.01144547155.52
72 rdf:rest N9b9356e45f8e46c7949bffb525b71ef1
73 N598ec75cd65844e9850c5f3247101dec schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
74 schema:name Adult
75 rdf:type schema:DefinedTerm
76 N630f1364bc06428b91d01b5657f801bd schema:affiliation https://www.grid.ac/institutes/grid.30760.32
77 schema:familyName Bienemann
78 schema:givenName Mary E.
79 rdf:type schema:Person
80 N6556a3ab92794d05963611c36c6a73d4 schema:name nlm_unique_id
81 schema:value 7704052
82 rdf:type schema:PropertyValue
83 N6c2566060a2a48c7ba3874488b28b7ea rdf:first N9520187e102a43d1ad42f156fef45f0d
84 rdf:rest Na44f284135e246f1882a1fad5101e9e3
85 N72b3919857cb4e82b37a66b398b5a35a schema:name readcube_id
86 schema:value 1e2eb7181c8ec1614c60aa757baf9c7e89a77b2db834a9ad568835db1d03bff3
87 rdf:type schema:PropertyValue
88 N79e548e97ebb445aa11afad71a48f6be schema:name doi
89 schema:value 10.1007/s00268-001-0019-2
90 rdf:type schema:PropertyValue
91 N7c326084853d4847a3252d850aca4383 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
92 schema:name Calcium Channel Agonists
93 rdf:type schema:DefinedTerm
94 N817d1efd97f44b86bdf5e7bfad8ed1c2 schema:name dimensions_id
95 schema:value pub.1006336571
96 rdf:type schema:PropertyValue
97 N9520187e102a43d1ad42f156fef45f0d schema:affiliation https://www.grid.ac/institutes/grid.30760.32
98 schema:familyName DoffekB.S.
99 schema:givenName Kara M.
100 rdf:type schema:Person
101 N9b92cfe4fd9942b3a1373828961dcdff schema:name pubmed_id
102 schema:value 11376403
103 rdf:type schema:PropertyValue
104 N9b9356e45f8e46c7949bffb525b71ef1 rdf:first sg:person.014277375462.62
105 rdf:rest N6c2566060a2a48c7ba3874488b28b7ea
106 N9de53d339f5a45e8b84ecb43b14c2267 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
107 schema:name Parathyroidectomy
108 rdf:type schema:DefinedTerm
109 N9e1c2634a0fe48a2a8c51519341e88c9 rdf:first N2a31b089d92e48daa82d28c162aa6f16
110 rdf:rest Nb177ffa8279c48bb96e13dd9281a8ea1
111 Na1c9fc66a6bd487b9b8fa3b4d0ccf784 schema:volumeNumber 25
112 rdf:type schema:PublicationVolume
113 Na44f284135e246f1882a1fad5101e9e3 rdf:first N2534e7bbe75f48c898f3d2773bd7e0f3
114 rdf:rest N228152ef85924ba9b1876c3fc55f44c5
115 Nb177ffa8279c48bb96e13dd9281a8ea1 rdf:first sg:person.01333432724.26
116 rdf:rest Nea1064e41d22442a90db41a97d454329
117 Nc143cf8989b4426cbeb39de88ff9237e schema:issueNumber 6
118 rdf:type schema:PublicationIssue
119 Ncb4f04cb01434693829216ed0711ac22 schema:name Springer Nature - SN SciGraph project
120 rdf:type schema:Organization
121 Nd6b088779d924588b5d570200ba0a855 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
122 schema:name Male
123 rdf:type schema:DefinedTerm
124 Ne469c9e49b2f4cec9492e3411118585d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
125 schema:name Humans
126 rdf:type schema:DefinedTerm
127 Ne64d5c54d9f145988144145292d7b74d rdf:first sg:person.0675722264.21
128 rdf:rest N9e1c2634a0fe48a2a8c51519341e88c9
129 Nea1064e41d22442a90db41a97d454329 rdf:first sg:person.01121231554.53
130 rdf:rest rdf:nil
131 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
132 schema:name Medical and Health Sciences
133 rdf:type schema:DefinedTerm
134 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
135 schema:name Clinical Sciences
136 rdf:type schema:DefinedTerm
137 sg:journal.1086446 schema:issn 0364-2313
138 1432-2323
139 schema:name World Journal of Surgery
140 rdf:type schema:Periodical
141 sg:person.01121231554.53 schema:affiliation https://www.grid.ac/institutes/grid.30760.32
142 schema:familyName Demeure
143 schema:givenName Michael J.
144 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01121231554.53
145 rdf:type schema:Person
146 sg:person.01144547155.52 schema:affiliation https://www.grid.ac/institutes/grid.30760.32
147 schema:familyName Decker
148 schema:givenName P. Anthony
149 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01144547155.52
150 rdf:type schema:Person
151 sg:person.01333432724.26 schema:affiliation https://www.grid.ac/institutes/grid.30760.32
152 schema:familyName Wilson
153 schema:givenName Stuart D.
154 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01333432724.26
155 rdf:type schema:Person
156 sg:person.014277375462.62 schema:affiliation https://www.grid.ac/institutes/grid.30760.32
157 schema:familyName Cohen
158 schema:givenName Eric P.
159 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014277375462.62
160 rdf:type schema:Person
161 sg:person.0675722264.21 schema:affiliation https://www.grid.ac/institutes/grid.30760.32
162 schema:familyName Zhu
163 schema:givenName Yong Ran
164 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0675722264.21
165 rdf:type schema:Person
166 sg:pub.10.1007/bf02385267 schema:sameAs https://app.dimensions.ai/details/publication/pub.1039906294
167 https://doi.org/10.1007/bf02385267
168 rdf:type schema:CreativeWork
169 https://doi.org/10.1002/(sici)1098-2388(199703/04)13:2<73::aid-ssu2>3.0.co;2-z schema:sameAs https://app.dimensions.ai/details/publication/pub.1003039741
170 rdf:type schema:CreativeWork
171 https://doi.org/10.1159/000188833 schema:sameAs https://app.dimensions.ai/details/publication/pub.1020421807
172 rdf:type schema:CreativeWork
173 https://www.grid.ac/institutes/grid.30760.32 schema:alternateName Medical College of Wisconsin
174 schema:name Department of Internal Medicine, Medical College of Wisconsin, 9200 West Wisconsin Avenue, Milwaukee, Wisconsin 53226, USA, US
175 Department of Surgery, Medical College of Wisconsin, 9200 West Wisconsin Avenue, Milwaukee, Wisconsin 53226, USA, US
176 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...